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Objectives: The inhibitory action of the superficial gingival connective tissues may 
limit the regenerative potential of alveolar bone in periodontal therapy or dental im-
plant applications. The aims of this study were to investigate the hypothesis that 
gingival fibroblasts (GF) can inhibit bone morphogenetic protein (BMP)- induced os-
teoblastic differentiation, to determine their expression of BMP inhibitors, and finally 
to determine whether reduction of these inhibitors can relieve suppression of osteo-
blastic differentiation.
Methods: Gingival fibroblasts were co- cultured either directly or indirectly with cal-
varial osteoblasts to assess alkaline phosphatase inhibitory activity, a marker of os-
teoblastic differentiation. To test total BMP- inhibitory activity of rat GF, conditioned 
media (GFCM) were collected from cultures. ROS 17/2.8 osteoblastic cells were 
stimulated with BMP2, together with GFCM. Inhibitor expression was tested using 
RT- qPCR, Western blotting and in situ hybridization. Removal of inhibitors was car-
ried out using immunoprecipitation beads.
Results: Co- culture experiments showed GF- secreted factors that inhibit BMP- 
stimulated ALP activity. 10 ng/ml BMP2 increased alkaline phosphatase expression in 
ROS cells by 41%. GFCM blocked BMP activity which was equivalent to the activity of 
100 ng/ml Noggin, a well- described BMP inhibitor. Cultured gingival fibroblasts consti-
tutively expressed BMP antagonist genes from the same subfamily, Grem1, Grem2 and 
Nbl1 and the Wnt inhibitor Sfrp1. Gremlin1 (6.7 × reference gene expression) had high-
est levels of basal expression. ISH analysis showed Gremlin1 expression was restricted 
to the inner half of the gingival lamina propria and the PDL. Removal of Gremlin1 pro-
tein from GFCM eliminated the inhibitory effect of GFCM on ALP activity in ROS cells. 
Subsequent addition of recombinant Gremlin1 restored the inhibitory activity.
Conclusions: Factors secreted by gingival fibroblasts inhibit BMP- induced bone for-
mation and a range of BMP inhibitors are constitutively expressed in gingival connec-
tive tissues. These inhibitors, particularly Gremlin1, may limit coronal alveolar bone 
regenerative potential during oral and periodontal surgery.
K E Y W O R D S
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1  | INTRODUC TION
New bone formation in periodontal regenerative treatments is 
generally restricted to infrabony sites. With a horizontal pattern of 
bone loss, regeneration is typically limited by encroachment of the 
overlying gingival connective tissues. Undesirable invasion by soft 
connective tissue negatively influences both the extent and nature 
of the bone formed;1 whilst elsewhere in the body clinical, develop-
mental and experimental observations suggest that bone formation 
can be inhibited by non- ossifying connective tissues.2 The biologi-
cal basis for this effect may be due to competition for the available 
space adjacent to bone; however, an alternative hypothesis is that 
fibroblasts constitutively exert inhibitory activity that limits bone 
growth.
Bone morphogenetic proteins (BMPs) are critical for osteogene-
sis and are unique in their ability to induce bone formation de novo in 
ectopic sites3 by induction of osteoblastic commitment of multipo-
tent mesenchymal stem cells.4,5 In rodent and feline mandibular fen-
estration defect models, BMP2 enhances healing and regeneration 
of bone tissue but does not lead to lasting ankylosis.6,7 Interestingly, 
doses well in excess of the physiological range are required to induce 
significant bone formation. BMP activity is tightly regulated at both 
the extra and intracellular levels, including by secretion of BMP an-
tagonists such as Gremlin1 and Noggin.8 Therefore, it is suggested 
that osteogenic inhibitory influences from connective tissue may in-
volve these inhibitors.
The aim of this study was to test the hypothesis that bone forma-
tion is inhibited by the production of inhibitory factors within the gin-
gival connective tissues. Our specific objectives were to test whether 
gingival cells inhibited osteoblast differentiation, to characterize the 
expression of bone inhibitory factors by the gingiva and to identify 
specific inhibitory factors which may be responsible for this activity.
2  | MATERIAL S AND METHODS
2.1 | Cell cultures
Primary fibroblasts were isolated from gingivae of 7- 8 week post- 
natal male Wistar rats (180- 200 g) (Charles Rivers, Margate, UK). 
Animal tissues were derived in accordance with UK Home Office ap-
proved animal use protocols. Briefly, immediately after sacrifice, sam-
ples were harvested using scalpels and minced into small fragments 
before plating onto culture dishes to allow cell outgrowth. Primary 
osteoblasts were isolated from calvariae of 1- 3 day post- natal Wistar 
rats by sequential collagenase digestion as previously described.9 
Primary rat femoral bone marrow stromal cells (BMSCs) were isolated 
from 5- 6 week post- natal male Wistar rats (100- 120 g) as previously 
described.10 MC3T3- E1 mouse pre- osteoblastic (MC3T3) cells were 
purchased from ATCC (catalogue number CRL- 2593). All cell cultures 
were expanded using α- MEM (Gibco, Paisley, UK) supplemented with 
10% newborn calf serum (NCS) (First Link, Birmingham, UK), 50 U/
ml penicillin, 50 ug/ml streptomycin, 0.3 μg/ml Fungizone (both 
Gibco, Paisley, UK) termed standard medium. The rat osteosarcoma 
cell line ROS 17/2.811 was cultured with standard medium. Details of 
fibroblast- osteoblast collagen gel and transwell co- culture methods 
can be found in the Supporting information Appendix S1.
2.2 | Media conditioning
Nearly, confluent primary cell cultures were washed three 
times with PBS prior to addition of serum- free standard media. 
Conditioned media (CM) were collected after 24 hours, passed 
through 0.22 μm filters (Nunc, Loughborough, UK) to remove any 
cellular debris and stored at −20°C until further use. Prior to use 
in experiments, 10% NBCS was added to CM. Details of methods 
to characterize conditioned media can be found in the Supporting 
Material file.
2.3 | Osteoblast proliferation and 
differentiation assays
5 × 103 ROS17/2.8 or primary calvarial cells were seeded in 96- 
well plates for 24 hours in standard media. Cell cultures were 
treated with conditioned media and recombinant mouse (rm)BMP2, 
rmGremlin1 or rmNoggin (all from R&D Systems, Abingdon, UK). 
72 hours following treatment proliferation was assessed using 
MTS assay according to the manufacturer’s instructions (CellTiter 
96 AQueous One Solution Cell Proliferation assay; Promega, 
Southampton, UK) followed immediately by an assay of alkaline 
phosphatase (ALP) activity to assess osteoblastic differentiation. 
ALP activity was assayed as described previously12 (all reagents 
from Sigma- Aldrich, Gillingham, UK).
2.4 | Migration assays
Migration of calvarial cells was tested using a 48 well chemotaxis 
chamber according to our previously described methods.13 Details 
are shown in Supporting information Appendix S1. Migration of cells 
towards recombinant rmBMP2 or rmPDGFbb (R&D Systems) over 
4 hours was tested.
2.5 | RT- qPCR analysis
Total RNA was extracted from cultured cells and expression of se-
creted BMP and Wnt inhibitors was determined by RT- qPCR with 
TaqMan Gene expression assays (Applied Biosystems, Warrington, 
UK) as described in detail in the Supporting information Appendix S1.
2.6 | In situ hybridization
Mouse Grem1, Grem2, Nbl1 and Nog riboprobes were generated from 
clones kindly supplied by Professor Richard Harland, Department of 
Molecular & Cell Biology, University of California, Berkeley. Plasmid 
and probe generation information is summarized in Tables 1 in the 
Supporting information Appendix S1. Plasmid DNA was linearized 
and antisense 35S- UTP radio- labelled riboprobes generated.
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Eight- week- old wild- type male C57BL/6 mice were killed by 
cervical dislocation. Mandibles and maxillae were isolated and fixed 
in 4% (w/v) paraformaldehyde overnight, washed with PBS, then 
decalcified with Morse’s solution.14 End point of decalcification 
was determined chemically by testing residual calcium. Specimens 
were then dehydrated through a graded ethanol series. Following 
this, specimens were then embedded in paraffin wax and sectioned 
at 7 μm, prior to section in situ hybridization.
Section radioactive in situ hybridization was carried out as previ-
ously described.15 Light- and dark- field images of sections were pho-
tographed using a Zeiss Axioscop microscope and merged in Adobe 
Photoshop CS.
2.7 | Immunoprecipitation
The Dynabeads Protein G IP kit (Invitrogen, Paisley, UK) was used 
for immunoprecipitation of Gremlin1 from conditioned media ac-
cording to the manufacturer’s instructions. Details are shown in the 
Supporting information Appendix S1.
2.8 | Western blotting analysis
The presence of Gremlin1 protein was tested in conditioned media 
and in eluted proteins from IP beads, by Western Blot. Details are 
shown in the Supporting information Appendix S1.
F IGURE  1 A, Effect of gingival fibroblasts on ALP activity in collagen matrix culture systems. Gingival fibroblasts were seeded with 
calvarial osteoblasts into collagen matrices. Control: ALP level of 5 × 105 osteoblasts grown in matrices containing 1 × 106 osteoblasts. 
Cal. + Ging.: ALP level of 5 × 105 osteoblasts grown in matrices with 5 × 105 gingival fibroblasts. Cal. + (2 × Ging.): ALP level of 5 × 105 
osteoblasts grown in matrices with 1 × 106 gingival fibroblasts. B and C, Effect of gingival fibroblast (B) and calvarial osteoblast (C) matrices 
on calvarial ALP activity. Control: ALP level of cultured calvarial osteoblasts in no matrix. Irradiated Matrix: ALP level osteoblasts grown on 
gingival or osteoblastic matrices obtained by irradiation. Frozen Matrix: ALP level of calvarial osteoblasts grown on gingival or osteoblastic 
matrices obtained by freeze/thaw cycles. D, Inhibition of total ALP activity of cells of the osteoblastic lineage co- cultured in the presence 
of gingival fibroblasts. Gingival fibroblasts were seeded onto cell culture membrane inserts and placed into wells 24 hours after seeding 
of either primary rat calvarial osteoblasts, primary rat bone marrow stromal cells (BMSC) and the murine osteoblastic line MC3T3- E1. ALP 
levels measured 72 hours after adding fibroblasts. Control: Osteoblast lineage cells cultured in wells without cells on inserts. Co- culture 
with same cell type: Osteoblast lineage cells grown on both surfaces. All values normalized to control. ALP activity adjusted for cell number 
in all experiments. Minimum of three replicates per experiment. Data shown as mean ± SD. Representative data from three independent 
experiments are shown. Significant differences shown as * (P < 0.05). Significance tested using one- way ANOVA with Bonferroni post- tests
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2.9 | Statistical analysis
Data are expressed as means ± SD. To allow meaningful comparison 
between different experiments, the values were normalized to the 
control (background) levels of ALP adjusted for cell number. One- 
way ANOVA was used to determine whether differences in alkaline 
phosphatase activity and expression of inhibitors in the different cell 
type were statistically significant from controls. All ANOVA analyses 
were examined post hoc by Bonferroni’s post- test. Statistical analy-
sis was carried out using Prism v5 software (GraphPad Software Inc., 
California). The statistical significance was set at P < 0.05.
3  | RESULTS
3.1 | Gingival fibroblasts inhibit osteoblastic 
differentiation
Gingival fibroblasts inhibited differentiation of primary calvarial 
osteoblasts when cultured with an equal number of gingival fi-
broblasts seeded simultaneously in collagen matrices (Figure 1A). 
Furthermore, the inhibition was further enhanced to a significant 
level when gingival fibroblast number was doubled. Gingival fi-
broblasts similarly inhibited differentiation when seeded 24 hours 
after calvarial osteoblasts in collagen matrices, implicating a 
F IGURE  2 A, Inhibition of ALP activity of calvarial osteoblasts when treated with different conditioned media (CM). B, Parallel cell 
proliferation assay of osteoblasts treated with different CM. Control, standard media; GFCM, Gingival fibroblast CM; COCM, Calvarial 
osteoblast CM. C, Inhibition of ROS cell ALP activity with dilution of GFCM. GFCM diluted with standard media. D, Normalized ROS cell 
ALP activity treated with heat- treated (1- 10 minutes) GFCM. Control: standard media. Heat treatment—GFCM placed in boiling water for 
1, 5 or 10 minutes. E, Normalized ROS cell ALP activity of treated with molecular weight fractionated GFCM. > indicates concentrates, < 
filtrates. ALP activity adjusted for cell number in all experiments. Minimum of three replicates per experiment. Data shown as mean ± SD. 
Representative data from three independent experiments are shown. Significant differences shown as *(P < 0.05). Significance tested using 
one- way ANOVA with Bonferroni post- tests
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paracrine mechanism due to reduced direct fibroblast to osteo-
blast contact. However, inhibition was not significantly further 
enhanced by doubling gingival fibroblast number (Supporting in-
formation Figure S1).
To test whether live fibroblasts were needed to produce the 
previously observed inhibition of osteoblastic differentiation, 
the effect of cell matrices was tested. Osteoblastic differentia-
tion was significantly inhibited when calvarial osteoblasts were 
seeded onto gingival fibroblast matrices obtained following irra-
diating cells by UV irradiation for 18 hours (Supporting informa-
tion Figure 1B). When matrices were obtained following repeated 
freeze- thaw cycles, a similar level of inhibition was achieved. In 
contrast, irradiated calvarial osteoblast matrices did not signifi-
cantly alter osteoblastic differentiation, whereas the matrix ob-
tained after freeze- thawing significantly enhanced differentiation 
(Figure 1C).
In transwell cultures, ALP levels were significantly reduced 
in cells tested at different stages of the osteoblast lineage—pri-
mary calvarial osteoblasts, bone marrow stromal stem cells and 
MC3T3 cells—when co- cultured with fibroblasts (Figure 1D). Co- 
culture with the same cells did not significantly alter osteoblastic 
differentiation.
3.2 | Gingival fibroblast conditioned media inhibits 
osteoblastic differentiation
Gingival fibroblast conditioned media (GFCM) significantly inhib-
ited calvarial osteoblast differentiation (Figure 2A), whilst having 
no significant effect on proliferation (Figure 2B). Interestingly, 
calvarial osteoblast conditioned medium also lowered ALP levels 
(Figure 2A) which could be explained by its effect of stimulating 
osteoblast proliferation thus diminishing a differentiation response 
(Figure 2B).
GFCM were subsequently applied to the rat osteosarcoma 
cell line ROS 17/2.8 in order to establish a reproducible model 
of osteoblastic differentiation in terms of ALP levels. Dilution 
of GFCM resulted in a non- linear reduction in inhibitory activ-
ity retaining approximately 40% of the effect at a 1:10 dilution 
(Figure 2C).
3.3 | Further characterization of GFCM activity
Inhibitory activity of GFCM was heat- labile, being rendered inactive 
after 5 minutes of boiling (Figure 2D). To further confirm whether 
GFCM inhibitory activity was proteinaceous in nature, trypsin was 
added to GFCM. Inhibitory activity was abolished by incubation with 
trypsin for 2 hours (after which protease inhibitor was added to in-
activate residual trypsin to allow the GFCM to be subsequently as-
sayed). Incubation of protease inhibitor alone had no effect on ROS 
cell ALP activity (Supporting information Figure S2). Fractionation 
of GFCM by molecular mass revealed inhibitory activity was main-
tained in fractions below 50 kDa, and activity was partially lost in 
fractions above 30 kDa (Figure 2E).
3.4 | BMP2 overcomes the inhibitory 
activity of GFCM
Increasing BMP2 concentrations partially reversed the inhibitory 
effects of GFCM on osteoblastic differentiation in both primary 
calvarial osteoblasts (25 ng/ml) (Figure 3A) and ROS cells (10 ng/ml) 
(Supporting information Figure S3) restoring ALP activity to baseline 
control levels. In ROS cells, the inhibitory activity of GFCM was com-
pletely reversed by addition of 25 ng/ml BMP2.
We next investigated whether this effect was similar to that 
caused by known BMP antagonists. 100 ng/ml Gremlin1 and 100 ng/
ml Noggin inhibited osteoblastic differentiation to a similar extent 
as that caused by GFCM (Figure 3B). 100 ng/ml noggin completely 
inhibited the stimulatory effect of 10 ng/ml BMP2 in control cultures 
(Figure 3C), whereas addition of 10 ng/ml BMP2 completely over-
came inhibition of GFCM (Figure 3D). GFCM therefore possessed 
BMP inhibitory activity that mimicked the action of BMP antagonists 
and was equivalent to approximately 100 ng/ml noggin. Furthermore, 
the inhibitory effect of GFCM appears to be saturated as it was not 
enhanced further by the addition of either 50 ng/ml or 100 ng/ml 
noggin (Figure 3D). GFCM also significantly inhibited calvarial os-
teoblast BMP- stimulated chemotaxis at concentrations up to 10 ng/
ml (Figure 3E). Again, this was to a similar extent as that caused by 
50 ng/ml noggin but GFCM did not inhibit PDGF- stimulated chemo-
taxis indicating selective inhibition (data not shown).
3.5 | BMP inhibitor expression in gingival tissues
Cultured gingival fibroblasts constitutively expressed genes of a 
number of BMP antagonists from the same DAN subfamily, Grem1, 
Grem2 and Nbl1 and the Wnt inhibitor Sfrp1 (Figure 4A). Grem1 
was the most expressed inhibitor (6.5× reference gene level) at ap-
proximately 12 times the level of the next most expressed Grem2. 
Interestingly, Noggin was not expressed. Of these genes, only Grem2 
expression was regulated by BMP2, with expression significantly 
upregulated twofold 2 hours post- stimulation with 100 ng/ml BMP2 
before returning to baseline levels by 24 hours (data not shown).
In situ hybridization of mouse periodontal tissue revealed consti-
tutive expression of Grem1 restricted to the inner half of the gingival 
connective tissue and periodontal ligament. However, expression of 
Grem2, Nbl1, Noggin was undetectable (Figure 4B).
3.6 | Gremlin1 contributes to the inhibitory 
activity of GFCM
Owing to the high expression in gingival fibroblasts, we investigated 
the effect of depleting Gremlin1 from GFCM on osteoblastic differ-
entiation by immunoprecipitation (IP). Loss of inhibitory activity was 
subsequently assessed using the ROS cell ALP activity assay.
Gremlin1 was detectable in untreated GFCM following con-
centration using a 5 kDa filter (Figure 4C). Two merged bands at 
22 kDa and 25 kDa were seen, mostly likely representing non- 
glycosylated and glycosylated forms of Gremlin1, respectively. 
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Gremlin1 was depleted using immunoprecipitation beads with or 
without anti- Gremlin1 antibody adsorbed, indicating non- specific 
removal. Adsorption of an irrelevant isotype control antibody for 
the neuron- specific protein, choline acetyltransferase (ChAT) visi-
bly removed less Gremlin1 than beads either with or without anti-
body to Gremlin1 bound.
IP- depleted GFCM resulted in total loss of inhibitory activity 
in the ROS cell ALP activity assay (Figure 4D). In contrast, GFCM 
treated using beads with ChAT antibody retained an inhibitory ef-
fect on ALP activity. Inhibition of ALP activity was completely re-
covered by adding 100 ng/ml Gremlin1 to both GFCM treated with 
Gremlin1 antibody (32% reduction in ALP activity compared to the 
control) and with plain beads (30% reduction in ALP activity), con-
firming the results of the previous tests.
4  | DISCUSSION
The results of this study show that gingival fibroblasts secrete BMP 
antagonists, most abundantly Gremlin1, leading to in vitro reduction 
of ALP activity, a marker of osteoblastic differentiation in both primary 
calvarial osteoblasts and a rat osteosarcoma cell line. Furthermore, de-
pletion of this BMP antagonist resulted in a recovery of ALP activity.
To date, biological methods of enhancing bone regeneration in 
clinical use have centred on the promotion of osteoinduction. In 
vitro, BMPs are potent differentiation factors, inducing the differ-
entiation of multipotential mesenchymal cells into osteochondro-
genic lineage cells and osteoblast precursor cells.5,16,17 BMPs are 
expressed during alveolar bone regeneration.18,19 Indeed, the ad-
dition of BMP2 is also able to significantly improve the results of 
F IGURE  3 A, Normalized osteoblastic ALP activity cultured in gingival fibroblast conditioned media (GFCM) treated with BMP2. B, ROS 
cell ALP activity following treatment with 10 ng/ml BMP2, 100 ng/ml Noggin, 100 ng/ml Gremlin1 and GFCM. Single dose stimulations 
employed. C, ROS cell ALP activity stimulated by 10 ng/ml BMP2 is inhibited by 100 ng/ml noggin. Single dose stimulations employed D. 
10 ng/ml BMP2 overcomes inhibitory effect on ALP activity of GFCM in ROS cells. Single dose stimulations used. Control in all experiments 
was standard media. ALP activity assessed after 72 hours and adjusted for cell number in all experiments. E, Inhibitory effect of GFCM 
on BMP2- stimulated calvarial osteoblast chemotaxis. Five counts per well. Minimum of three replicates per experiment. Data shown as 
mean ± SD. Representative data from three independent experiments are shown. Significant differences shown as *P < 0.05 to BMP- 
matched control, †P < 0.05 to baseline control. Significance tested using one- way ANOVA with Bonferroni post- tests
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guided tissue regeneration in human patients,20 but require large 
supraphysiological doses. Therefore, targeting BMP inhibitors may 
provide a novel means of improving bone regeneration and achiev-
ing other relevant osteogenic needs.
Studies of the interaction of tissues during embryogenesis sug-
gest that mesenchymal tissues can define the boundary of bone 
formation by the expression of soluble molecules such as the 
BMP inhibitor noggin.2 New bone formation readily occurs in suit-
able environmental niches such as at a properly reduced fracture 
site or indeed within alveolar bone following implant placement. 
However, the extent of new bone formation is generally limited by 
the different environment surrounding the site of bone formation.
The inhibition of osteoblastic differentiation caused by gingival 
fibroblasts following sequential seeding in collagen gels was of a 
F IGURE  4 A. Relative expression of BMP and BMP inhibitor genes by cultured gingival fibroblasts Expression normalized to averaged 
Eif4a2 and Atp5b expression. Data shown as mean ± SD (n = 5 animals). Assays carried out in triplicate. *P < 0.05—Grem1 expression 
significantly higher than all others tested. Significance tested by one- way ANOVA with Bonferroni post- tests. B, In situ hybridization of 
BMP inhibitor mRNA expression in molar periodontal tissue of 8 wk post- natal WT mice. A, H&E staining, B, Grem1 expression restricted 
to the inner half of the gingival lamina propria closest to the alveolar bone and periodontal ligament. C- E, Expression of Grem2 (D), Nbl1 (E) 
and Noggin (F) undetectable. OE, oral epithelium; SE, sulcular epithelium; S, sulcus; D, dentine; PL, periodontal ligament; AB, alveolar bone; 
*, processing artefact. Scale bar in F = 100 μm for A- E (n = 2 mice). Results confirmed in two independent experiments. C, Western blotting 
of gingival fibroblast conditioned media confirming the presence of Gremlin1 and removal with immunoprecipitation beads. Lanes: No IP—
Concentrated gingival fibroblast conditioned media containing proteins >5 kDa, IP- Grem1—Concentrated GFCM treated with IP beads with 
Gremlin1 antibody adsorbed, IP- control—Concentrated GFCM treated with IP beads with isotype control antibody adsorbed, IP- beads—
GFCM treated with IP beads without antibody adsorbed. 10 μg total protein/well loaded. D, Inhibition of ROS cell ALP activity of Gremlin1- 
depleted gingival fibroblast conditioned medium is rescued with addition of Gremlin1. GFCM that underwent IP were analysed in the ROS 
cell ALP activity assay. SM—standard media. GFCM—concentrated GFCM. IP- Grem1—Concentrated GFCM treated with IP beads with 
Gremlin1 antibody adsorbed. IP- beads—GFCM treated with IP beads without antibody adsorbed. IP- control—Concentrated GFCM treated 
with IP beads with isotype control antibody adsorbed, Grem1—100 ng/ml rmGremlin1 added immediately prior to ROS assay. No Grem1—no 
Gremlin1 added. Results shown as mean ± SD. *—significantly different from standard media with no Gremlin1, †—significantly different 
from matched sample without Gremlin1 added. P < 0.05. Each treatment tested using five replicates from 1 cell line. Representative results 
from experiments testing three independent primary cell lines. Significance tested using one- way ANOVA with Bonferroni post- tests
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similar extent to that caused by simultaneously seeding (Figure 1 and 
Supporting information Figure S1) indicating that a paracrine mech-
anism was involved. Enhancement of inhibition caused by doubling 
the number of fibroblasts seeded in both cases provides evidence 
for a dose- dependent nature. The inhibition caused by matrices of 
devitalized gingival fibroblasts demonstrated signals can persist 
which remain inhibitory to calvarial osteoblast ALP production. The 
lack of inhibition caused by calvarial matrices demonstrated the se-
lective nature of the inhibition.
Paracrine- mediated inhibition of osteoblastic differentiation at 
multiple stages of the osteoblastic lineage was shown in primary 
BMSCs, MC3T3, and calvarial osteoblasts when co- cultured with 
gingival fibroblasts. Although calvarial osteoblasts were inhibited 
to the greatest degree. Collectively, the results verify gingival fibro-
blasts influence the differentiation activity of osteoblasts indepen-
dent of physical contact.
A reproducible model of the system using ROS cells that 
showed a good response in terms of the inhibition of ALP syn-
thesis was established and was also able to sensitively respond 
to BMP2 whilst demonstrating the antagonistic activity of BMP 
inhibitors. Furthermore, the lack of inhibition on PDGF- mediated 
osteoblast chemotaxis by GFCM, provides further evidence of 
the selectivity.
The maintenance of inhibition of ROS cell ALP activity at low 
concentrations of conditioned medium implied complex reaction 
kinetics. Application of conditioned media caused no observable 
change to cell morphology and nutrient depletion was unlikely 
to be a factor due to the short period of generation. The data 
suggest- high affinity binding where a low concentration of a fac-
tor is required to maintain a significant inhibition. Although ex-
ogenously applied BMP2 has been shown to regulate Gremlin1 
expression in developmental models, it had no effect on expres-
sion in gingival fibroblasts, suggesting it may be regulated by an 
alternative BMP or different ligand class. Interestingly, Gremlin1 
has also been postulated to have a BMP- independent role in dif-
ferentially modulating angiogenesis dependent upon its dimeric 
state via binding of vascular endothelial growth factor (VEGF) 
receptor 2 (VEGFR2)21 and is associated in renal development 
and upregulated in fibrotic conditions of the kidney, lung22,23 and 
rheumatoid arthritis.24
ISH analysis showed Gremlin1 expression was found to be re-
stricted to the inner gingival lamina propria closest to the alveolar 
bone and periodontal ligament suggesting the presence of region-
ally specific subpopulations of fibroblasts, as with the dermis.25 
Fibroblasts that populate the superficial papillary dermis have 
been shown to be morphologically and physiologically distinct 
from fibroblasts derived from the deeper reticular dermis.26 Irwin 
et al27 compared human gingival cells derived from the two layers 
and showed that papillary fibroblasts proliferated faster and were 
smaller and more spindly. Groeneveld et al28 observed the inner 
part of the gingiva exhibits markedly higher ALP activity than the 
outer area.
The high relative level of Gremlin1 expression suggests that it 
may play an important role in regulating osteogenesis within the 
periodontium. Reduction of the non- specific immunoprecipitation 
binding was attempted using a number of techniques; however, 
binding of Gremlin1 to beads was not reduced. The restoration of 
the inhibitory effect on ALP activity by adding rmGremlin1 to GFCM 
following treatment using beads suggests Gremlin1 is at least partly 
responsible for the inhibitory effect of GFCM. Addition of 100 ng/
ml rmGremlin1 did not further increase inhibitory activity when 
added to the untreated GFCM providing further evidence that in the 
ROS cell assay inhibitory activity is saturated by factor(s), such as 
Gremlin1, in GFCM alone.
Overall, the data provide compelling evidence that Gremlin1 
plays a role in inhibiting osteoblastic differentiation. This is in agree-
ment with existing evidence showing siRNA knockdown of a number 
of inhibitors including Gremlin1 enhances osteoblastic differentia-
tion.29-33 Furthermore, an engineered BMP2 variant that competi-
tively inhibits antagonists has been shown to enhance bone healing 
in critical size defect model.34
Gremlin1 plays an important role in bone development29 
and has been suggested to be an important marker for identify-
ing osteochondroreticular cells within long bones.35 Gremlin1 
knockout mice die shortly after birth due to kidney agenesis 
and also have significant limb bone abnormalities.36 Conditional 
knockout of Gremlin1 targeted to osteoblasts causes a transient 
increase in trabecular bone volume due to increased osteoblas-
tic activity during growth,29 whereas transgenic mice overex-
pressing Gremlin1 become osteopenic due to decreased bone 
formation.37 Further detailed analysis of the effects on dental 
development of Gremlin1 overexpression revealed defective 
enamel and dentine formation with enlarged pulp spaces and 
alveolar bone resorption at root apices due to inflammation.38 
The other abnormality of the periodontal tissues observed was 
that the PDL was less cellular, but no differences in cementum 
or alveolar bone were noted. This effect of overexpression 
implies Gremlin1 potentially plays a site- specific role within 
the periodontium involving regulation of cell proliferation or 
differentiation. Overall, this implies BMP inhibitors may have 
important roles independent of osteogenesis including regula-
tion of cell cycle and potential interaction with other signalling 
pathways.
5  | CONCLUSION
Gingival fibroblasts express Gremlin1 inhibiting osteoblastic differ-
entiation mediated by BMP2. Overall, factors secreted by gingival 
connective tissue inhibit BMP- induced bone formation, and a range 
of BMP inhibitors are constitutively expressed in gingival connec-
tive tissues. The results suggest these BMP inhibitors, particularly 
Gremlin1, may play a role in regulating formation and regeneration 
of bone at the hard- soft tissue interface.
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